Global Pleural Diseases Therapeutics MarketThe global market for pleural diseases therapeutics is projected to experience ...

AllianceQUANTRO Therapeutics and IMP enter into research collaboration to accelerate transcriptomic drug discovery 24.10.2024 / 09:30 CET/CESTThe issuer is solely responsible for the content of this ...

In 2023, the market is anticipated to be valued at USD 26.64 Billion, marking a significant starting point for a decade-long ...

The global Chronic Obstructive Pulmonary Disease (COPD) treatment market is projected to experience steady growth over the ...

As our digital focus continues, Daniel Ghinn explores the growing anticipation around Boehringer Ingelheim’s launch of Syrum – the first pharmaceutical social game – ahead of its beta launch ...

Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term, sustainable perspective. More than 53,000 employees serve over 130 markets in the two business units Human Pharma ...

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den ...

Boehringer Ingelheim has taken an option on a family ... broad activity against the symptoms of the disorder. The German pharma company is paying a signing fee of €25 million for the portfolio ...

To our knowledge, this is the first intestinal ultrasound appropriateness rating exercise conducted for defining, diagnosing, ...

The global Cattle & Porcine/Swine Reproductive Diseases market is expected to grow to USD 975.8 Million by 2029, up from USD ...

Global Astrocytoma Market is valued approximately at USD 1.1 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 3% over the forecast period 2024-2032. Read the Market ...